Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia

Clinical Journal of Pain

Volumn 21, Issue 2, 2005, Pages 182-184

  Allam, Nasser ^a   Brasil Neto, Joaquim P ^a   Brown, Gilberto ^b   Tomaz, Carlos ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

Author keywords

Botulinum toxin; Pain alleviation; Trigeminal neuralgia

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; CARBAMAZEPINE; GLYCEROL; PHENOL;

AGED; ANALGESIA; ARTICLE; CASE REPORT; DAILY LIFE ACTIVITY; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HEALTH STATUS; HUMAN; INTRACTABLE PAIN; MALAISE; MALE; PAIN ASSESSMENT; PARESIS; PRIORITY JOURNAL; RADIODIAGNOSIS; TREATMENT WITHDRAWAL; TRIGEMINUS NEURALGIA; VISUAL ANALOG SCALE;

AGED; BOTULINUM TOXINS; FACIAL PAIN; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; PAIN MEASUREMENT; PAIN, INTRACTABLE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIGEMINAL NEURALGIA;

EID: 14044257232     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200503000-00010     Document Type: Article

References (33)

1. Joffroy A, Levivier M, Massager N. Trigeminal neuralgia. Pathophysiology and treatment. Acta Neurol Belg. 2001;101:20-25.
2. Das B, Saba SP. Trigeminal neuralgia: current concepts and management. J Indian Med Assoc. 2001;99:704-709.
3. Kranzl B, Kranzl C. Drug treatment of trigeminal neuralgia with sympatho- and parasympatholytics. J Maxillofac Surg. 1976;4:56-60.
4. Weiss JL, Weiss KL, Benecke SM. Serotonin mediated cluster headache, trigeminal neuralgia, glossopharyngeal neuralgia, and superior laryngeal neuralgia with SAD chronicity. Child Psychiatry Hum Dev. 2001;32:45-54.
5. Aoki KR. Development of BOTOX. Its history and pharmacology. Pain Digest. 1998;8:337-341.
6. Greene P, Kang U, Fahn S, et al. Double-blind, placebo-controlled trial of botulinum toxins injections for the treatment of spasmodic torticollis. Neurology. 1990;40:1213-1218.
7. Jankovick J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990;40:277-280.
8. Gobel H, Deusehl G. Dauerkontraktionen kranialer oder zervikaler muskeln-wenn dystonien kopfschmerz beriten. Munch Med W Sehr. 1999;139:30-31.
9. Brin MF, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord. 1987;2:237-254.
10. Schoenen J, Noordhout AM. Headache. In: Wall PD, Melzak R, eds. Textbook of Pain. 3rd ed. Edinburgh: Churchill Livingstone; 1994:495-521.
11. Acquandro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin [letter]. Anesthesiology. 1994;80:705-706.
12. Porta M. Botulinum toxin type A injections for myofascial pain syndromes and tension-type headache. Eur J Neurol. 1999;6(suppl 4):S103-S110.
13. Foster L, Clapp L, Erickson M, et al. Botulinum toxin A and chronic low back pain: a randomized, double blind study. Neurology. 2001;56:1290-1293.
14. Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40:445-450.
15. Barwood S, Bailllieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol. 2000;42:116-121.
16. Rosales RL, Arimura K, Takenaga S, et al. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve. 1996;19:488-496.
17. Fillipi GM, Enrico P, Santarelli R, et al. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993;113:400-404.
18. Travell JG, Simons DG. The Trigger Point Manual. Baltimore: Williams & Wilkins; 1993.
19. Giladi N. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci. 1997;152:132-135.
20. Ishikawa H, Mitsui Y, Yoshitomi T, et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol. 2000; 44:106-109.
21. Purkiss J, Welch M, Doward S, et al. Capsaicin-stimulates release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol. 2000;59:1403-1406.
22. Yokosawa N, Suga K, Kimura K, et al. Exogenous zinc ion is required for inhibitory activity of botulinum neurotoxin C1 against norepinephrine release and its endopeptidase activity toward substance P. Biochem Mol Biol Int. 1994;32:455-463.
23. Welch MJ, Purkiss JR, Forster KA. Sensitivity of embryonic dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon. 2000;38:245-258.
24. Humm AM, Pasbt C, Lauterburg T, et al. Enkephalin and a FGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin. Ex D Neurol. 2000;161:361-372.
25. Van den Bergh P, De Beukelaer M, Deconinck N. Effect of muscle denevation on the expression of substance P in the ventral raphe-spinal pathway of the rat. Brain Res. 1996;707:206-212.
26. Wiegand H, Erdmann G, Welhoner HH. 1251-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292:161-165.
27. Wiegand H, Welhoner HH. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol. 1977;298:235-238.
28. Benecke R, Hagenah R, Wiegand H. Effects of type A botulinum toxin on some synaptic transmissions in the spinal cord of cats. Pflugers Arch. 1975;359:90.
29. Hagenah R, Benecke R, Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at la inhibitory interneurons. Naunyn Schmiedebergs Arch Pharmacol. 1977;299:267-272.
30. Guyer BM. Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain. 1999;3:427-431.
31. Verderio C, Coco S, Rossetto O, et al. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J Neurochem. 1999;73:372-379.
32. Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon. 2000;38:245-258.
33. Ishikawa H, Mitsui Y, Yoshitomi T, et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol. 2000; 44;106-109.